Overexpression of EGFR activates downstream signaling pathways including PI3K/AKT and MEK/ERK signaling, resulting in aggressive growth and invasive related phenotypes in cells [7], such as tumor cell motility, adhesion, metastasis, as well as angiogenesis. The gene discussed is MAP2K7; the disease is neoplasm.